- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 114.29M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 127.06M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 112.34M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $6.37M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $9.23M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $1.25M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $30.78M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $28.77M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $4.97M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $4.89M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $50.47M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $81.19M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $43.1M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $58.59M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $97.1M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $113.03M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $131.93M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $154.44M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $400.88M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $423.1M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.02 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.06 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $15.94M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $14.62M |
| Net Income | Q1 2026 · Mar 31, 2026 | $2.92M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$6.7M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $5.04M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$440K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $20.99M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $14.18M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $29.25M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $25.5M |
| Revenue | Q1 2026 · Mar 31, 2026 | $50.24M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $39.68M |